factual
Derivatives Desk Pricing Revealed Biotech Investing Interest
Working on Merrill Lynch's derivatives desk, Karnal was assigned to biotech and found the life-or-death risk-reward setting compelling enough to pursue a career in life sciences investing.
factualpending
Speaker
Alex KarnalEvidence Quote
“I actually never picked biotech. When I got moved over to the derivatives desk, I was just put into biotech.”
Source
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the BestCreated: 11/14/2026, 4:24:39 AM
Your notes
Loading notes...